Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.51T | 37x | 8.79 | SEK 1,618.50 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 109.56B | 50.2x | -1.33 | SEK 319.20 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.8% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 34.49B | 148x | -3.72 | SEK 588.50 | -9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.9% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.84B | 179.8x | 1.22 | SEK 41.60 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.4% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 21.81B | 74.7x | 0.07 | SEK 330 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 9.88B | 24.6x | -7.71 | SEK 98 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.1% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.36B | 84.1x | 1.97 | SEK 40.16 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.2% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.55B | -421.6x | SEK 45.48 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Probi AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3B | 219.2x | -7.39 | SEK 263 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 639.60M | -18.5x | -0.32 | SEK 3.98 | 15.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 633.03M | 62.3x | -6.46 | SEK 33 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.3% Upside | Upgrade to Pro+ | |
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 617.23M | -5.2x | -0.21 | SEK 11.90 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 501.02M | -11.9x | -0.49 | SEK 10.71 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 465.81M | -4.8x | -0.1 | SEK 13.50 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 463.42M | -3.3x | 0.17 | SEK 34.80 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 402.90M | -4.4x | 0.09 | SEK 23.41 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 327.69M | -5.7x | -0.46 | SEK 1.89 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 299.10M | -3.2x | -0.18 | SEK 14.40 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 237.06M | -3.9x | -0.09 | SEK 3.92 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 164.19M | -25.5x | 0.03 | SEK 7.64 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 138.89M | -15.1x | -0.29 | SEK 4.94 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 137.74M | -1.4x | -0.02 | SEK 0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Spotlight | Healthcare | Pharmaceuticals | SEK 132.94M | -2.8x | -0.06 | SEK 0.17 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 118.30M | -5.4x | -0.33 | SEK 10.46 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -90.6% Downside | Upgrade to Pro+ | |
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 116.72M | -0.4x | -0.15 | SEK 0.14 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CS Medica AS | Spotlight | Healthcare | Pharmaceuticals | SEK 116.27M | -13.5x | 0.27 | SEK 8.42 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 71.92M | -0.9x | -0.02 | SEK 0.86 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 52.99M | -2x | -1.34 | SEK 1.54 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 48.70M | 226.6x | 1.3 | SEK 3.18 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ziccum | Stockholm | Healthcare | Pharmaceuticals | SEK 36.39M | -2.5x | -0.19 | SEK 2.30 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |